| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/15/2002 | US6338942 Selective expansion of target cell populations |
| 01/15/2002 | US6338845 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 01/15/2002 | US6338844 Genomic nucleic acids, cDNA and mRNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 01/15/2002 | CA2036894C Vectors and compounds for expression of glycosylation mutants of human protein c |
| 01/15/2002 | CA2001719C Phosphorylated fusion proteins and uses related thereto |
| 01/13/2002 | CA2312051A1 Methylated nucleotide regulation of gene expression |
| 01/10/2002 | WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 01/10/2002 | WO2002003052A2 Laser scanning cytology with digital image capture |
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002789A2 Compositions and methods for producing recombinant virions |
| 01/10/2002 | WO2002002787A1 Elicitor from cladosporium |
| 01/10/2002 | WO2002002783A2 Expression vectors |
| 01/10/2002 | WO2002002780A2 Human serine-threonine kinase |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002769A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002750A1 Culturing pancreatic stem cells having a specified, intermediate stage of development |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002738A2 Host cells containing multiple integrating vectors |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002639A2 Human ion channels |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002619A1 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002159A1 Base materials for tissue regeneration, transplant materials and process for producing the same |
| 01/10/2002 | WO2002002152A1 Photodynamic treatment and uv-b irradiation of a thrombocyte suspension |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2002001950A2 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | WO2001085973A9 Antisense type gene trap vector |
| 01/10/2002 | WO2001075084A3 Coffee mannanase |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001048145A3 High affinity tcr proteins and methods |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045495A3 Potassium channel stress-related proteins and methods of use in plants |
| 01/10/2002 | WO2001044480A3 Enzymes and genes used for producing vanillin |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001040307A8 Antibodies against signal regulator proteins |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001037850A3 Use of a milk protein hydrolysate in the treatment of diabetes |
| 01/10/2002 | WO2001037656A3 Preservation of sensitive biological material |
| 01/10/2002 | WO2001036615A3 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001018050A3 T2r taste receptor family |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000075300A3 Methods for manipulating the avian genome |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004938 Models of prion disease |
| 01/10/2002 | US20020004706 Apparatus and method for automated protein design |
| 01/10/2002 | US20020004587 Antibody for use in the treatment of cancer; antitumor agents |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004488 Gene therapy |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004241 Use of beta-catenin in the expansion of stem and progenitor cells |
| 01/10/2002 | US20020004240 Method and system for introducing a gene into a human stem cell |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004227 Nucleotide sequences coding immunoglobulins; for use in treating cancer |
| 01/10/2002 | US20020004225 Activating bone development in mammals; prepare activator, adminster to mammal, monitor mammal for bone development |
| 01/10/2002 | US20020004203 Reduced activity of polymerase chain reactions |
| 01/10/2002 | US20020004194 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 01/10/2002 | US20020004076 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | US20020004044 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | US20020004041 Inducing tolerance in mammals to antigen via isolating peripheral blood mononuclear cells, then isolating dendritic cells and exposing to apoptotic cells in absence of cell surface glycoprotein receptors for HIV; prophylaxis |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | US20020004038 Dual chamber dispenser to receive centrifuged blood; stores, individually, activated blood components; isolates thrombin; all components for surgical bioadhesive derived from patient |
| 01/10/2002 | DE10128980A1 Genetically modified T cells, useful e.g. for inhibiting allogenic transplant rejection, produced by incubating recipient and donor T cells then transducing with immunomodulatory gene |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10030149A1 Use of novel polypeptide or its variant or nucleic acid encoding the polypeptide for diagnosing and/or preventing and/or treating skin disorders and/or treatment in wound healing or for identifying active substances |
| 01/10/2002 | CA2585012A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |